CooperVision focuses on developing and manufacturing a wide range of soft contact lenses, addressing various vision correction needs such as nearsightedness, farsightedness, astigmatism, and presbyopia. The segment's research and development efforts are directed towards creating innovative lens designs and materials that enhance comfort, vision quality, and overall eye health. Technologies like advanced lens polymers, optimized optics, and precision manufacturing processes are employed to deliver superior product performance. CooperVision's lenses cater to diverse patient populations, including those with specific conditions like myopia and ocular dryness, aiming to improve their quality of life through enhanced vision. The segment maintains a strong market position through continuous innovation, strategic partnerships, and a commitment to meeting the evolving needs of eye care professionals and patients worldwide.

CooperSurgical is dedicated to advancing women's health by providing a comprehensive portfolio of medical devices, fertility solutions, and diagnostic products. The segment's research and development activities are centered on developing innovative technologies for fertility treatments, minimally invasive surgical procedures, and improved diagnostic accuracy. Key areas of focus include fertility consumables and equipment, preimplantation genetic testing, and surgical instruments for gynecological procedures. CooperSurgical's products aim to improve patient outcomes in areas such as fertility, obstetrics, and gynecology, addressing critical needs in women's healthcare. The segment's market positioning is strengthened by its commitment to quality, innovation, and strategic acquisitions, enabling it to offer a broad range of solutions to healthcare professionals and patients globally. Future growth opportunities lie in expanding its product offerings, entering new markets, and fostering collaborations with leading medical institutions.